S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 37 of 37

Issue Date	Title / Author(s) / Citation	File
2004	Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells Lee, Jung Weon; Ko, Seong Gyu; Kim, Hwang-Phill; Jin, Dong-Hoon; Bae, Hyun-Su; Kim, Sung Hoon; Park, Chong-Hyeong Cancer Letters 220 (2005) 11–19	view file link
2004	TGF-β1 (transforming growth factor-β1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellularsignal-regulated kinases) cascade activity dependent on c-Src activity Lee, Jung Weon; Kim, Hwang-Phill; Lee, Mi-Sook; Yu, JiYon; Park, Jin-Ah; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Biochem. J. (2004) 379, 141–150	view file link
2004	Smad2 mediates Erk1/2 activation by TGF-ß1 in suspended, but not in adherent, gastric carcinoma cells Lee, Jung Weon; Lee, Mi-Sook; Ko, Seong-Gyu; Kim, Hwang-Phill; Kim, Yong-Bae; Lee, Sung-Yul; Kim, Sang-Gyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue INTERNATIONAL JOURNAL OF ONCOLOGY 24: 1229-1234, 2004	view file link
2004-04	TGF-β1 (transforming growth factor-β1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellularsignal-regulated kinases) cascade activity dependent on c-Src activity Kim, Hwang-Phill; Lee, Mi-Sook; Yu, Ji Yon; Park, Jin-Ah; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Bang, Yung-Jue Biochemical Journal, Vol.379, pp.141-150	DOI
2004-05	Smad2 mediates Erk1/2 activation by TGF-beta 1 in suspended, but not in adherent, gastric carcinoma cells Lee, Mi-Sook; Ko, Seong-Gyu; Kim, Hwang-Phill; Kim, Yong-Bae; Lee, Sung-Yul; Kim, Sang-Gyun; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Bang, Yung-Jue INTERNATIONAL JOURNAL OF ONCOLOGY Vol.24 No.5, pp. 1229-1234
2004-05	Smad2 mediates Erk1/2 activation by TGF-β1 in suspended, but not in adherent, gastric carcinoma cells Lee, Mi-Sook; Ko, Seong-Gyu; Kim, Hwang-Phill; Kim, Yong-Bae; Lee, Sung-Yul; Kim, Sang-Gyun; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Bang, Yung-Jue International Journal of Oncology, Vol.24 No.5, pp.1229-1234	DOI
2005	TGF-h1-mediated activations of c-Src and Rac1 modulate levels of cyclins Lee, Jung Weon; Kim, Hwang-Phill; Kim, Tai-Young; Lee, Mi-Sook; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Biochim. Biophys. Acta 1743 (2005) 151– 161	view file link
2005-03	TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin Kim, Hwang-Phill; Kim, Tai-Young; Lee, Mi-Sook; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Bang, Yung-Jue Biochim Biophys Acta. 2005 Mar 22;1743(1-2):151-61.	link
2005-03	TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin Kim, Hwang-Phill; Kim, Tai-Young; Lee, Mi-Sook; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Bang, Yung-Jue Biochim Biophys Acta. 2005;1743(1-2):151-61.	link
2006-09	Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells Lee, Keun-Wook; Kim, Jee Hyun; Park, Jung-Hyun; Kim, Hwang-Phill; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Tai Young; Jong, Hyun-Soon; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Noe Kyeong; Bang, Yung-Jue Anticancer Research, Vol.26 No.5A, pp.3429-3438
2007-03	DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma Kim, Tai Young; Lee, Jung Weon; Kim, Hwang-Phill; Jong, Hyun-Soon; Kim, Tae-You; Jung, Mira; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.355 No.1, pp.72-77	DOI
2007-04	Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323	DOI
2008	DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Park, Jung-Hyun; Kim, Hwang-Phill; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2462-2471	DOI
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI
2008-03	Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Lee, Keun-Wook; Kim, Sang Gyun; Kim, Hwang-Phill; Kwon, Euna; You, Jiran; Choi, Hyung-Jun; Park, Jung-Hyun; Kang, Byeong-Cheol; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Res. 2008 Mar 15;68(6):1916-26.	link
2008-03	Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Lee, Keun-Wook; Kim, Sang Gyun; Kim, Hwang-Phill; Kwon, Euna; Yons, Jiran; Choi, Hyung-Jun; Park, Jung-Hyun; Kang, Byeong-Cheol; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Research, Vol.68 No.6, pp.1916-1926	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2008-12	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines Kim, Jin Won; Kim, Hwang-Phill; Im, Seock-Ah; Kang, Soyeong; Hur, Hyung Seok; Yoon, Young-Kwang; Oh, Do-Youn; Kim, Jee Hyun; Lee, Dong Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.272 No.2, pp.296-306	DOI
2009-06	Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2 Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Jin-Won; Han, Sae-Won; Hur, Hyung-Seok; Park, Jinah; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You PLoS ONE, Vol.4 No.6, p. e5933	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2010-12	RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase Lee, Kyung-Hun; Hur, Hyung-Seok; Im, Seock-Ah; Lee, Juhee; Kim, Hwang-Phill; Yoon, Young-Kwang; Han, Sae-Won; Song, Sang-Hyun; Oh, Do-Youn; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.299 No.1, pp.22-28	DOI
2011-03	Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Hur, Hyung-Seok; Song, Sang-Hyun; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.302 No.2, pp.155-165	DOI
2012-02	Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition. Lee, Mi-Sook; Kim, Hwang-Phill; Kim, Tae-You; Lee, Jung Weon BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH Vol.1823 No.2, pp. 514-523	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Song, Sang-Hyun; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Letters, Vol.316 No.1, pp.77-84	DOI
2012-03	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You PLoS ONE, Vol.7 No.3, p. e0033322	DOI
2012-07	Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Yun, Jiyeon; Song, Sang-Hyun; Park, Jinah; Kim, Hwang-Phill; Yoon, Young-Kwang; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.92 No.7, pp.1033-1044	DOI
2012-08	Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer Yoon, Young-Kwang; Im, Seock-Ah; Min, Ahrum; Kim, Hwang-Phill; Hur, Hyung-Seok; Lee, Kyung-Hun; Han, Sae-Won; Song, Sang-Hyun; Oh, Do Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Letters, Vol.321 No.2, pp.128-136	DOI
2012-12	The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Song, Sang-Hyun; Min, Ah-Rum; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.6, pp.2148-2160	DOI
2013-01	Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Im, Seock-Ah; Oh, Do-Youn; Elvin, Paul; Kim, Hwang-Phill; Yoon, Young-Kwang; Min, Ahrum; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.1, pp.16-26	DOI
2013-05	Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing Han, Sae-Won; Kim, Hwang-Phill; Shin, Jong-Yeon; Jeong, Eun-Goo; Lee, Won-Chul; Lee, Kyung-Hun; Won, Jae-Kyung; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You PLoS ONE, Vol.8 No.5, p. e64271	DOI
2013-06	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib Min, Ahrum; Im, Seock-Ah; Yoon, Young-Kwang; Song, Sang-Hyun; Nam, Hyun-Jin; Hur, Hyung-Seok; Kim, Hwang-Phill; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Kim, Woo-Ho; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.6, pp.865-877	DOI
2013-07	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.335 No.1, pp.145-152	DOI
2019-05	Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Bae, Jeong Mo; Kim, Hwang-Phill; Lyu, Jaemyun; Han, Hyojun; Kim, Hyoki; Jang, Hoon; Bang, Duhee; Won, Jae-Kyung; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You BMC Cancer. 19(1):421	view file DOI
2022-06	Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer Cho, Young-Won; Min, Dong-Wook; Kim, Hwang-Phill; An, Yohan; Kim, Sheehyun; Youk, Jeonghwan; Chun, Jaeyoung; Im, Jong Pil; Song, Sang-Hyun; Ju, Young Seok; Han, Sae-Won; Park, Kyu Joo; Kim, Tae-You Molecular Oncology, Vol.16 No.12, pp.2396-2412	DOI